alendronate has been researched along with Anti-MuSK Myasthenia Gravis in 2 studies
alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Alendronate was stopped, and he was started on intravenous ibandronate injections given every 3 months." | 5.40 | Exacerbation of myasthenia gravis by alendronate. ( Alay, S; Güzelküçük, U; Kesikburun, S; Tan, AK; Yavuz, F, 2014) |
| "Alendronate was stopped, and he was started on intravenous ibandronate injections given every 3 months." | 1.40 | Exacerbation of myasthenia gravis by alendronate. ( Alay, S; Güzelküçük, U; Kesikburun, S; Tan, AK; Yavuz, F, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lv, F | 1 |
| Guan, Y | 1 |
| Ma, D | 1 |
| Xu, X | 1 |
| Song, Y | 1 |
| Li, L | 1 |
| Jiang, Y | 1 |
| Wang, O | 1 |
| Xia, W | 1 |
| Xing, X | 1 |
| Li, M | 1 |
| Kesikburun, S | 1 |
| Güzelküçük, U | 1 |
| Alay, S | 1 |
| Yavuz, F | 1 |
| Tan, AK | 1 |
2 other studies available for alendronate and Anti-MuSK Myasthenia Gravis
| Article | Year |
|---|---|
Effects of alendronate and alfacalcidol on bone in patients with myasthenia gravis initiating glucocorticoids treatment.
Topics: Aged; Alendronate; Asian People; Bone and Bones; Bone Density; Bone Remodeling; Drug Therapy, Combin | 2018 |
Exacerbation of myasthenia gravis by alendronate.
Topics: Alendronate; Bone Density Conservation Agents; Diphosphonates; Glucocorticoids; Humans; Ibandronic A | 2014 |